| Literature DB >> 16925504 |
Bart J F van den Bemt1, Frank H J van den Hoogen, Ferdinand C Breedveld, Hille van der Tempel, Rob Janknegt.
Abstract
This article offers an interactive decision matrix technique (InforMatrix), in which a group of experts in rheumatology determine an order of merit within the various biologicals used for rheumatoid arthritis. In this order of merit, six criteria (efficacy, safety, tolerance, ease of use, applicability and costs) are weighed against each other. Data necessary for this weighing process are derived from both literature, as well as clinical practice experience. This article provides an overview of the most relevant clinical trials on the biologicals, as well as a description of the interactive decision matrix technique. Using this interactive matrix technique makes rational consideration of the treatment options for rheumatoid arthritis possible.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16925504 DOI: 10.1517/14656566.7.13.1769
Source DB: PubMed Journal: Expert Opin Pharmacother ISSN: 1465-6566 Impact factor: 3.889